There is limited experience with overdose of<unk> .<unk>  has been assessed in single doses of as high as 240mg in clinical studies. The medication dose-dependently produces somnolence. High doses of<unk>  may also cause sleep-onset paralysis in some individuals (2% incidence at doses of 40–240mg). Treatment of<unk>  overdose is based on symptoms and is supportive. Gastric lavage may be used where appropriate whereas the value of dialysis has not been determined. Because<unk>  has high plasma protein binding, hemodialysis is not expected to enhance elimination of<unk> .
Suvorexant
Icatibant
Veristrat
Seltorexant
Daridorexant
Rimegepant
Atogepant
Ubrogepant